abstract |
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof, n n n n n n n n n n wherein A, B, C, R, R 1 , R 2 , R 3 , R 4 and R 5 are as herein described, and wherein said methods of use include uses for the treatment and/or prevention of disorders and diseases, such as diabetes. |